Not applicableStudy completedNCT02973204What this trial is testingCirculating Tumor Cells and Tumor DNA in HCC and NETWho this might be right forCarcinoma, HepatocellularNeuroendocrine Tumors University of Aarhus 167
Not applicableLooking for participantsNCT05053555What this trial is testingHigh Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesWho this might be right forLiver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more M.D. Anderson Cancer Center 60
Not applicableLooking for participantsNCT07377487What this trial is testingTheraSphere Japan Pre-Market StudyWho this might be right forLiver Neoplasms Boston Scientific Corporation 51
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Active Not RecruitingNCT04234568What this trial is testingTesting the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine TumorsWho this might be right forMetastatic Digestive System Neuroendocrine NeoplasmMetastatic Neuroendocrine Tumor National Cancer Institute (NCI) 31
Early research (Phase 1)Looking for participantsNCT06066138What this trial is testingTherapeutic Drug Monitoring-Based Atezolizumab DosingWho this might be right forLocally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Early research (Phase 1)Ended earlyNCT04596033What this trial is testingTiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck+6 more Genocea Biosciences, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT05500508What this trial is testingOral AMXT 1501 Dicaprate in Combination With IV DFMOWho this might be right forCancerSolid TumorSolid Carcinoma+17 more Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT03071757What this trial is testingThe Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 139
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271What this trial is testingBOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsWho this might be right forHepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more Sotio Biotech Inc. 7
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Not applicableNo Longer AvailableNCT02431715What this trial is testing18F-FDOPA PET in Neuroendocrine TumoursWho this might be right forThyroid Cancer, MedullaryCarcinoid TumorPheochromocytoma+3 more British Columbia Cancer Agency
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Testing effectiveness (Phase 2)UnknownNCT03638206What this trial is testingAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesWho this might be right forB-cell Acute Lymphoblastic LeukemiaLymphomaMyeloid Leukemia+13 more Shenzhen BinDeBio Ltd. 73
Testing effectiveness (Phase 2)Study completedNCT00353015What this trial is testingIrinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractWho this might be right forGastrointestinal CancerCarcinoma, Neuroendocrine M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Post-approval studies (Phase 4)Study completedNCT01525550What this trial is testingThe Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsWho this might be right forWell-differentiated Pancreatic Neuroendocrine Tumor Pfizer 106